Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Clinical journal of the American Society of Nephrology : CJASN - 1 Jan 2006

Bresin Elena, Daina Erica, Noris Marina, Castelletti Federica, Stefanov Rumen, Hill Prudence, Goodship Timothy H J, Remuzzi Giuseppe

Abstract excerpt

More than 50% of patients with non-Shiga toxin-associated hemolytic uremic syndrome (non-Stx-HUS) progress to ESRD. Kidney transplant failure for disease recurrence is common; hence, whether renal transplantation is appropriate in this clinical setting remains a debated issue. The aim of this study was to identify possible prognostic factors for renal transplant outcome by focusing on specific genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CFH gene
Share to Hemolytic-Uremic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Mutation

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 17699195
DOI: 10.2215/CJN.00050505

Genes

CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.PMID 17699195Read ↗

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.Semantic proximity Read ↗

Recurrence of hemolytic uremic syndrome after renal transplantation.Semantic proximity Read ↗

Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.Semantic proximity Read ↗

Thrombotic microangiopathy after kidney transplantation.Semantic proximity Read ↗

The hemolytic uremic syndromes.Semantic proximity Read ↗

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Semantic proximity Read ↗

Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.Semantic proximity Read ↗

Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome.Semantic proximity Read ↗

Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.Semantic proximity Read ↗

The importance of genetic mutation screening to determine retransplantation following failed kidney allograft from recurrent atypical haemolytic ureamic syndrome.Semantic proximity Read ↗

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.Semantic proximity Read ↗

Posttransplant recurrence of atypical hemolytic uremic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.